Oral epithelial dysplasia is a precancerous change in the lining of the mouth. It develops in the epithelium, the thin surface layer of cells that covers the inside of the oral cavity and acts as a protective barrier. In dysplasia, the epithelial cells grow and mature abnormally: they vary in size and shape, divide more often than they should, and lose their normal orderly arrangement from the bottom of the epithelium to the surface. These changes reflect damage that has accumulated in the genetic material of the cells.
The single most important thing to understand is that oral epithelial dysplasia is not cancer. The abnormal cells are still confined to the surface layer and have not grown into the tissue underneath, which is what defines an invasive cancer. What dysplasia does indicate is an increased risk that squamous cell carcinoma, the most common cancer of the mouth, could develop in that area over time. Most people diagnosed with oral epithelial dysplasia never go on to develop cancer, but the risk is high enough that the finding is taken seriously and followed carefully.
Dysplasia can develop anywhere in the mouth lined by squamous epithelium, but it is found most often on the side and undersurface of the tongue and on the floor of the mouth beneath the tongue. These are the highest-risk locations. It also occurs on the inner cheeks, the gums, the hard palate, and the inner surface of the lips.
This article will help you understand the findings in your pathology report, what each term means, and why it matters for your care.
Oral epithelial dysplasia, a precancerous change in the lining of the mouth, develops when the cells of that lining are damaged repeatedly over a long period. Each round of damage and repair leaves behind a small number of errors in the cells’ genetic material. Once enough errors accumulate in the genes that control growth and maturation, the cells stop behaving normally, and the pathologist recognizes this abnormal appearance as dysplasia.
The main causes and risk factors are:
Two points are worth emphasizing. First, dysplasia sometimes develops in people with none of these risk factors at all. A diagnosis in a lifelong non-smoker who does not drink is not unusual, particularly on the tongue, and it does not mean something was missed. Second, when the whole lining of the mouth has been exposed to tobacco, alcohol, or betel quid for years, the entire surface carries damage, not only the visible patch. Pathologists call this field change. It explains why a new area of dysplasia can appear somewhere else in the mouth after the first one has been removed, and it is a central reason that follow-up continues long term.
Most people with oral epithelial dysplasia, a precancerous change in the lining of the mouth, have no symptoms at all. The condition is frequently discovered by a dentist or hygienist during a routine examination, before the patient has noticed anything. When changes are noticed, they are usually visual rather than painful:
Because pain is usually absent and the appearance overlaps with many harmless conditions, dysplasia cannot be diagnosed by looking at the mouth. A biopsy is required. Any patch in the mouth that persists beyond two to three weeks, and particularly any red patch, deserves evaluation.
Oral epithelial dysplasia is diagnosed only when tissue from the abnormal area is examined under the microscope by a pathologist. The tissue is obtained by biopsy, usually a small piece taken from the most abnormal-looking part of the patch, and often including some adjacent normal-appearing lining for comparison. Neither the appearance of the patch in the mouth nor imaging can establish this diagnosis or determine its grade.
Under the microscope, the pathologist assesses two things together: how abnormal the individual cells look, and how disorganized the epithelium is as a whole. The pathologist then judges how far up through the thickness of the epithelium these changes extend, and combines all of this into a grade. Critically, the pathologist also confirms that the abnormal cells have not broken through the base of the epithelium into the tissue below. That downward growth is called invasion, and its absence is what separates dysplasia from invasive squamous cell carcinoma.
Your report may include a few descriptive terms alongside the diagnosis. Hyperkeratosis means a thickened layer of keratin on the surface, and it is what usually makes the area look white in the mouth. Parakeratosis and acanthosis describe other changes in the surface layer, and atypia means the cells look abnormal. These terms describe what the pathologist saw. They accompany the diagnosis rather than adding to it, and the grade remains the finding that matters most.
One limitation of the initial biopsy deserves emphasis, because it explains much of what happens next. A biopsy samples only a small part of the abnormal area, and the most abnormal region is not always the region that was sampled. In published series of patients with high-grade dysplasia on biopsy who then had the whole area removed, invasive cancer was already present in the removed tissue in roughly 18% of cases. A biopsy showing dysplasia therefore establishes a minimum, not a maximum, and this is a major reason complete removal is often recommended even when the biopsy shows no cancer.
Grading is the part of the report on oral epithelial dysplasia that carries the most weight, because the grade is the strongest single predictor of whether the abnormal area will progress to cancer. Two grading systems are in use, and different laboratories use different ones. Your report may use either, or both, so both are explained here.
The three-tier system. This is the system recommended by the World Health Organization and the one most reports use. It is based on how far up through the thickness of the epithelium the abnormal changes extend, judged alongside how severe the individual cell changes are.
The two-tier (binary) system. Some laboratories report dysplasia more simply as low-grade or high-grade. Mild dysplasia generally corresponds to low-grade and severe dysplasia to high-grade. Moderate dysplasia may be assigned to either, and it is the category where the two systems most often disagree.
Carcinoma in situ. Some reports use squamous cell carcinoma in situ as a fourth, highest category. In the mouth, this term is generally treated as equivalent to severe dysplasia rather than as a separate and more dangerous diagnosis. The word “carcinoma” in this phrase understandably causes alarm; carcinoma in situ means the abnormal cells still sit entirely within the surface layer and have not invaded, so it is not an invasive cancer.
One point is worth knowing, because patients sometimes obtain second opinions and find the grade has changed. Grading dysplasia is a judgment, not a measurement, and agreement between pathologists is only moderate. Published studies have found pathologists agree on the exact grade roughly half to two-thirds of the time, although agreement on whether dysplasia is present at all is considerably better. A change in grade on review is common and does not mean an error was made. It is one reason your treatment team weighs the grade together with the size and location of the lesion, its appearance, and your risk factors, rather than treating the grade as the only consideration.
When an area of oral epithelial dysplasia is removed completely rather than just sampled, the pathology report will describe the margins, the cut edges of the tissue removed. The pathologist inks the outer surfaces of the specimen and examines under the microscope whether dysplastic cells reach any edge.
Margins in dysplasia are interpreted differently from margins in cancer surgery, and this is worth understanding. Dysplasia often extends beyond what can be seen in the mouth, and the surrounding lining may already carry genetic damage that looks entirely normal under the microscope. A negative margin therefore means the abnormal-looking tissue was removed, not that the risk has been eliminated. Studies have found that achieving clear margins does not reliably prevent a new lesion or a cancer from developing at the same site, which is why surveillance continues after excision regardless of what the margins show. Reports may also note whether hyperkeratosis or lesser changes reach a margin; this carries less weight than dysplasia at a margin.
This is the question most people want answered, and it deserves specific numbers rather than reassurance. Oral epithelial dysplasia is a precancerous change in the lining of the mouth, and the majority of people who have it never develop cancer. Across pooled studies, roughly 12% of people diagnosed with oral epithelial dysplasia went on to develop oral squamous cell carcinoma, with a reported range of about 8% to 18%. Put the other way, close to nine out of ten did not. In a large population-based study, patients with dysplasia had a substantially higher risk of oral cancer than the general population, and that risk was highest in the first two years after diagnosis. When cancer does develop, the average interval is roughly four years, so the risk unfolds slowly and is one that follow-up is well suited to catch.
Risk rises with grade. In a recent meta-analysis of white patches in the mouth, the proportion that progressed to cancer was about 7% for mild dysplasia, 11% for moderate dysplasia, and 17% for severe dysplasia, compared with about 2% for patches showing no dysplasia at all. Expressed as an annual rate, published figures are roughly 1.7% per year for mild dysplasia and 3.6% per year for severe dysplasia. It is worth noting that in several studies the difference between mild and moderate dysplasia was not statistically significant, while severe dysplasia stood clearly apart. Notice also that even mild dysplasia carries real risk, which is why no grade is simply dismissed.
Factors on your report and in your history that increase risk include:
All of these figures are averages drawn from groups of patients followed over many years, in studies that used differing definitions and populations. They describe patterns, not a prediction for any one person, and your own risk is best discussed with the clinician who can see your lesion and knows your history.
Once oral epithelial dysplasia has been confirmed on biopsy, the next steps depend on the grade, the size and location of the abnormal area, its appearance, and your risk factors. The pathology report informs these decisions but does not determine them on its own, and there is genuine variation in practice because the evidence does not point to one clearly superior approach. Care is usually shared between an oral and maxillofacial surgeon, an ear nose and throat surgeon, an oral medicine specialist, and your dentist.
Broadly, two approaches are considered, often in combination:
It is worth being clear about what removal does and does not achieve. Excision reduces the risk of cancer developing at that site, and in one large series patients whose high-grade dysplasia was removed developed cancer at roughly half the rate of those who were not treated. However, removal does not eliminate the risk. Dysplasia recurs at the same site in roughly a quarter to a third of cases, and cancer can still develop in tissue that looked normal. For this reason, surveillance continues after excision rather than replacing it.
Alongside either approach, two things consistently matter. The first is stopping tobacco and reducing alcohol, which removes the ongoing damage driving the process and is the most effective step available to most patients. Support for quitting is a standard part of care and worth asking for. The second is regular follow-up examination of the entire mouth, not just the treated area, typically every three to six months at first and less often over time if the area remains stable. Because of field change, follow-up looks for new lesions elsewhere as well as recurrence at the original site, and it generally continues for many years rather than a fixed period.
by Jason Wasserman MD PhD FRCPC
July 24, 2026
Oral epithelial dysplasia is a precancerous change in the lining of the mouth. It develops in the epithelium, the thin surface layer of cells that covers the inside of the oral cavity and acts as a protective barrier. In dysplasia, the epithelial cells grow and mature abnormally: they vary in size and shape, divide more often than they should, and lose their normal orderly arrangement from the bottom of the epithelium to the surface. These changes reflect damage that has accumulated in the genetic material of the cells.
The single most important thing to understand is that oral epithelial dysplasia is not cancer. The abnormal cells are still confined to the surface layer and have not grown into the tissue underneath, which is what defines an invasive cancer. What dysplasia does indicate is an increased risk that squamous cell carcinoma, the most common cancer of the mouth, could develop in that area over time. Most people diagnosed with oral epithelial dysplasia never go on to develop cancer, but the risk is high enough that the finding is taken seriously and followed carefully.
Dysplasia can develop anywhere in the mouth lined by squamous epithelium, but it is found most often on the side and undersurface of the tongue and on the floor of the mouth beneath the tongue. These are the highest-risk locations. It also occurs on the inner cheeks, the gums, the hard palate, and the inner surface of the lips.
This article will help you understand the findings in your pathology report, what each term means, and why it matters for your care.
Oral epithelial dysplasia, a precancerous change in the lining of the mouth, develops when the cells of that lining are damaged repeatedly over a long period. Each round of damage and repair leaves behind a small number of errors in the cells’ genetic material. Once enough errors accumulate in the genes that control growth and maturation, the cells stop behaving normally, and this abnormal appearance is what the pathologist recognizes as dysplasia.
The main causes and risk factors are:
Two points are worth emphasizing. First, dysplasia sometimes develops in people with none of these risk factors at all. A diagnosis in a lifelong non-smoker who does not drink is not unusual, particularly on the tongue, and it does not mean something was missed. Second, when the whole lining of the mouth has been exposed to tobacco, alcohol, or betel quid for years, the entire surface carries damage, not only the visible patch. Pathologists call this field change. It explains why a new area of dysplasia can appear somewhere else in the mouth after the first one has been removed, and it is a central reason that follow-up continues long term.
Most people with oral epithelial dysplasia, a precancerous change in the lining of the mouth, have no symptoms at all. The condition is frequently discovered by a dentist or hygienist during a routine examination, before the patient has noticed anything. When changes are noticed, they are usually visual rather than painful:
Because pain is usually absent and the appearance overlaps with many harmless conditions, dysplasia cannot be diagnosed by looking at the mouth. A biopsy is required. Any patch in the mouth that persists beyond two to three weeks, and particularly any red patch, deserves evaluation.
Oral epithelial dysplasia is diagnosed only when tissue from the abnormal area is examined under the microscope by a pathologist. The tissue is obtained by biopsy, usually a small piece taken from the most abnormal-looking part of the patch, and often including some adjacent normal-appearing lining for comparison. Neither the appearance of the patch in the mouth nor imaging can establish this diagnosis or determine its grade.
Under the microscope, the pathologist assesses two things together: how abnormal the individual cells look, and how disorganized the epithelium is as a whole. The pathologist then judges how far up through the thickness of the epithelium these changes extend, and combines all of this into a grade. Critically, the pathologist also confirms that the abnormal cells have not broken through the base of the epithelium into the tissue below. That downward growth is called invasion, and its absence is what separates dysplasia from invasive squamous cell carcinoma.
Your report may include a few descriptive terms alongside the diagnosis. Hyperkeratosis means a thickened layer of keratin on the surface, and it is what usually makes the area look white in the mouth. Parakeratosis and acanthosis describe other changes in the surface layer, and atypia means the cells look abnormal. These terms describe what the pathologist saw. They accompany the diagnosis rather than adding to it, and the grade remains the finding that matters most.
One limitation of the initial biopsy deserves emphasis, because it explains much of what happens next. A biopsy samples only a small part of the abnormal area, and the most abnormal region is not always the region that was sampled. In published series of patients with high-grade dysplasia on biopsy who then had the whole area removed, invasive cancer was already present in the removed tissue in roughly 18% of cases. A biopsy showing dysplasia therefore establishes a minimum, not a maximum, and this is a major reason complete removal is often recommended even when the biopsy shows no cancer.
Grading is the part of the report on oral epithelial dysplasia that carries the most weight, because the grade is the strongest single predictor of whether the abnormal area will progress to cancer. Two grading systems are in use, and different laboratories use different ones. Your report may use either, or both, so both are explained here.
The three-tier system. This is the system recommended by the World Health Organization and the one most reports use. It is based on how far up through the thickness of the epithelium the abnormal changes extend, judged alongside how severe the individual cell changes are.
The two-tier (binary) system. Some laboratories report dysplasia more simply as low-grade or high-grade. Mild dysplasia generally corresponds to low-grade and severe dysplasia to high-grade. Moderate dysplasia may be assigned to either, and it is the category where the two systems most often disagree.
Carcinoma in situ. Some reports use squamous cell carcinoma in situ as a fourth, highest category. In the mouth, this term is generally treated as equivalent to severe dysplasia rather than as a separate and more dangerous diagnosis. The word “carcinoma” in this phrase understandably causes alarm; carcinoma in situ means the abnormal cells still sit entirely within the surface layer and have not invaded, so it is not an invasive cancer.
One point is worth knowing, because patients sometimes obtain second opinions and find the grade has changed. Grading dysplasia is a judgment, not a measurement, and agreement between pathologists is only moderate. Published studies have found pathologists agree on the exact grade roughly half to two-thirds of the time, although agreement on whether dysplasia is present at all is considerably better. A change in grade on review is common and does not mean an error was made. It is one reason your treatment team weighs the grade together with the size and location of the lesion, its appearance, and your risk factors, rather than treating the grade as the only consideration.
When an area of oral epithelial dysplasia is removed completely rather than just sampled, the pathology report will describe the margins, the cut edges of the tissue removed. The pathologist inks the outer surfaces of the specimen and examines under the microscope whether dysplastic cells reach any edge.
Margins in dysplasia are interpreted differently from margins in cancer surgery, and this is worth understanding. Dysplasia often extends beyond what can be seen in the mouth, and the surrounding lining may already carry genetic damage that looks entirely normal under the microscope. A negative margin therefore means the abnormal-looking tissue was removed, not that the risk has been eliminated. Studies have found that achieving clear margins does not reliably prevent a new lesion or a cancer from developing at the same site, which is why surveillance continues after excision regardless of what the margins show. Reports may also note whether hyperkeratosis or lesser changes reach a margin; this carries less weight than dysplasia at a margin.
This is the question most people want answered, and it deserves specific numbers rather than reassurance. Oral epithelial dysplasia is a precancerous change in the lining of the mouth, and the majority of people who have it never develop cancer. Across pooled studies, roughly 12% of people diagnosed with oral epithelial dysplasia went on to develop oral squamous cell carcinoma, with a reported range of about 8% to 18%. Put the other way, close to nine out of ten did not. In a large population-based study, patients with dysplasia had a substantially higher risk of oral cancer than the general population, and that risk was highest in the first two years after diagnosis. When cancer does develop, the average interval is roughly four years, so the risk unfolds slowly and is one that follow-up is well suited to catch.
Risk rises with grade. In a recent meta-analysis of white patches in the mouth, the proportion that progressed to cancer was about 7% for mild dysplasia, 11% for moderate dysplasia, and 17% for severe dysplasia, compared with about 2% for patches showing no dysplasia at all. Expressed as an annual rate, published figures are roughly 1.7% per year for mild dysplasia and 3.6% per year for severe dysplasia. It is worth noting that in several studies the difference between mild and moderate dysplasia was not statistically significant, while severe dysplasia stood clearly apart. Notice also that even mild dysplasia carries real risk, which is why no grade is simply dismissed.
Factors on your report and in your history that increase risk include:
All of these figures are averages drawn from groups of patients followed over many years, in studies that used differing definitions and populations. They describe patterns, not a prediction for any one person, and your own risk is best discussed with the clinician who can see your lesion and knows your history.
Once oral epithelial dysplasia has been confirmed on biopsy, the next steps depend on the grade, the size and location of the abnormal area, its appearance, and your risk factors. The pathology report informs these decisions but does not determine them on its own, and there is genuine variation in practice because the evidence does not point to one clearly superior approach. Care is usually shared between an oral and maxillofacial surgeon, an ear nose and throat surgeon, an oral medicine specialist, and your dentist.
Broadly, two approaches are considered, often in combination:
It is worth being clear about what removal does and does not achieve. Excision reduces the risk of cancer developing at that site, and in one large series patients whose high-grade dysplasia was removed developed cancer at roughly half the rate of those who were not treated. However, removal does not eliminate the risk. Dysplasia recurs at the same site in roughly a quarter to a third of cases, and cancer can still develop in tissue that looked normal. For this reason, surveillance continues after excision rather than replacing it.
Alongside either approach, two things consistently matter. The first is stopping tobacco and reducing alcohol, which removes the ongoing damage driving the process and is the most effective step available to most patients. Support for quitting is a standard part of care and worth asking for. The second is regular follow-up examination of the entire mouth, not just the treated area, typically every three to six months at first and less often over time if the area remains stable. Because of field change, follow-up looks for new lesions elsewhere as well as recurrence at the original site, and it generally continues for many years rather than a fixed period.